The treatment of cocaine use disorder
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
Current treatments for cocaine use disorder are often ineffective; new treatments are needed and are under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Psychosocial/behavioral interventions-such as contingency management, community reinforcement, and cognitive behavioral therapy -remain the standard and most reliably available practices for treatment of MUD (36) and CUD (37).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contingency management for treatment of substance use disorders: a meta‐analysis
Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01581.x · Cited by 877
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
Self-citationScofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 545
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529
Give them prizes and they will come: Contingency management for treatment of alcohol dependence.
Petry, N. M., Martin, B., Cooney, J. L., & Kranzler, H. R. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.2.250 · Cited by 515
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 459
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120061010 · Cited by 409
Carroll, K. M., Ball, S. A., Martino, S., Nich, C., Babuscio, T. A., Nuro, K. F., Gordon, M. A., Portnoy, G. A., & Rounsaville, B. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111835 · Cited by 405
Cited by
Microneedle patch for the ultrasensitive quantification of protein biomarkers in interstitial fluid
Wang, Z., Luan, J., Seth, A., Liu, L., You, M., Gupta, P., Rathi, P., Wang, Y., Cao, S., Jiang, Q., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00672-y · Cited by 386
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“It is also suggested that individuals suffering from obesity and individuals suffering from addiction have overlapping brain dysregulations, and the anti-obesity effects of GLP-1 receptor agonists support the potential usefulness of GLP-1 receptor agonists for the treatment of SUD and AUD.”
BackgroundInfluentialThe Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms
Jones, C. M., Bekheet, F., Park, J. N., & Alexander, G. C. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa011 · Cited by 188
Roque Bravo, R., Faria, A. C., Brito-da-Costa, A. M., Carmo, H., Mladěnka, P., Dias da Silva, D., Remião, F., & Researchers, O. B. O. T. O. (2022) · Toxins · doi:10.3390/toxins14040278 · Cited by 161
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05563-3 · Cited by 151
Cocaine Use Disorder (CUD): Current Clinical Perspectives
Schwartz, E. K. C., Wolkowicz, N. R., Aquino, J. P. D., MacLean, R. R., & Sofuoglu, M. (2022) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s337338 · Cited by 102
Consideration of sex and gender differences in addiction medication response
McKee, S. A., & McRae‐Clark, A. L. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00441-3 · Cited by 76
Trends and correlates of cocaine use among adults in the United States, 2006–2019
Mustaquim, D., Jones, C. M., & Compton, W. M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106950 · Cited by 76
Martinelli, S., Mazzotta, A. D., Longaroni, M., & Petrucciani, N. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.112424 · Cited by 70
Corbett, C. M., Dunn, E., & Loweth, J. A. (2021) · eNeuro · doi:10.1523/eneuro.0054-21.2021 · Cited by 70
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders
Newman, A. H., Ku, T. C., Jordan, C. J., Bonifazi, A., & Xi, Z. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-124205 · Cited by 67
Mews, P., Cunningham, A. M., Scarpa, J. R., Ramakrishnan, A., Hicks, E. M., Bolnick, S., Garamszegi, S. P., Shen, L., Mash, D. C., & Nestler, E. J. (2023) · Science Advances · doi:10.1126/sciadv.add8946 · Cited by 52
Lin, J. J., Arnovitz, M. D., Kotbi, N., & Francois, D. (2023) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-023-00291-9 · Cited by 47
Garza‐Villarreal, E. A., Alcalá‐Lozano, R., Fernandez‐Lozano, S., Morelos-Santana, E., Davalos-Guzman, A., Villicaña, V., Alcauter, S., Castellanos, F. X., & Gonzalez-Olvera, J. J. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.01.003 · Cited by 42
Gao, Z., Winhusen, T. J., Gorenflo, M., Ghitza, U. E., Davis, P. B., Kaelber, D. C., & Xu, R. (2023) · Addiction · doi:10.1111/add.16168 · Cited by 40
Clinical management of psychostimulant withdrawal: review of the evidence
Li, M. J., & Shoptaw, S. J. (2023) · Addiction · doi:10.1111/add.16093 · Cited by 39
Maldonado, R. J., Calvé, P., García‐Blanco, A., Domingo‐Rodriguez, L., Senabre, E., & Martín‐García, E. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108466 · Cited by 38
Ending Mass Incarceration: Why it Persists and How to Achieve Meaningful Reform
Beckett, K. (2022) · doi:10.1093/oso/9780197536575.001.0001 · Cited by 35
Potassium Channels and Their Potential Roles in Substance Use Disorders
McCoy, M. T., Jayanthi, S., & Cadet, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031249 · Cited by 34
de Guglielmo, G., Carrette, L. L. G., Kallupi, M., Brennan, M., Boomhower, B., Maturin, L., Conlisk, D., Sedighim, S., Tieu, L., Fannon, M. J., et al. (2024) · eLife · doi:10.7554/elife.90422.3 · Cited by 30
Calpe-López, C., Gasparyan, A., Navarrete, F., Manzanares, J., Miñarro, J., & Aguilar, M. A. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120965952 · Cited by 30
Aranäs, C., Caffrey, A., Edvardsson, C. E., Schmidt, H. D., & Jerlhag, E. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2025.07.001 · Cited by 31
DNA methylation in cocaine use disorder–An epigenome-wide approach in the human prefrontal cortex
Poisel, E., Zillich, L., Streit, F., Frank, J., Friske, M. M., Foo, J. C., Mechawar, N., Turecki, G., Hansson, A. C., Nöthen, M. M., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1075250 · Cited by 29
Stewart, A. F., Lepack, A. E., Fulton, S. L., Safovich, P., & Maze, I. S. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103824 · Cited by 29
Biomarkers of Relapse in Cocaine Use Disorder: A Narrative Review
Poireau, M., Milpied, T., Maillard, A., Delmaire, C., Volle, E., Bellivier, F., Icick, R., Azuar, J., Marie-Claire, C., Bloch, V., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12081013 · Cited by 28
Luján, M. Á., Alegre-Zurano, L., Martín‐Sánchez, A., Cantacorps, L., & Valverde, O. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110462 · Cited by 27
Histone modifications in cocaine, methamphetamine and opioids
Cheng, J., He, Z., Chen, Q., Jiang, L., Peng, Y., Zhang, J., Yan, X., Yan, J., & Niu, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16407 · Cited by 27
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
“Existing evidence indicates that there is a tremendous need for additional studies that focus on new neurobiological mechanisms of cocaine and novel strategies in treating CUD (Kampman, 2019; Volkow, 2020).”
BackgroundCocaine vaccine dAd5GNE protects against moderate daily and high-dose “binge” cocaine use
Havlicek, D. F., Rosenberg, J. B., De, B. P., Hicks, M. J., Sondhi, D., Kaminsky, S. M., & Crystal, R. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239780 · Cited by 25
Neuroinflammatory Response in Reward-Associated Psychostimulants and Opioids: A Review
Karimi‐Haghighi, S., Chavoshinezhad, S., Mozafari, R., Noorbakhsh, F., Borhani‐Haghighi, A., & Haghparast, A. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01223-6 · Cited by 24
Illicit Drug Use in Older Adults
Ghantous, Z., Ahmad, V., & Khoury, R. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.002 · Cited by 23
Trends of Cocaine Use and Manifestations in Hospitalized Patients: A Cross-Sectional Study
Gangu, K., Bobba, A., Basida, S. D., Avula, S. R., Chela, H. K., & Singh, S. (2022) · Cureus · doi:10.7759/cureus.22090 · Cited by 22
Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice
Ledesma, J. C., Manzanedo, C., & Aguilar, M. A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110390 · Cited by 22
Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders
Hofford, R. S., & Kiraly, D. D. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.08.004 · Cited by 20
Schmitz, J. M., Stotts, A. L., Vujanovic, A. A., Yoon, J. H., Webber, H. E., Lane, S. D., Weaver, M. F., Vincent, J. N., Suchting, R., & Green, C. E. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.111078 · Cited by 20
Castillo-Toledo, C., Fraile‐Μartinez, O., Donat‐Vargas, C., Lara-Abelenda, F. J., Ortega, M. A., Montero, C. G., Mora, F., Álvarez‐Mon, M., Quintero, J., & Álvarez-Mon, M. Á. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1282026 · Cited by 20
Gerace, E., Baldi, S., Salimova, M., Gloria, L. D., Curini, L., Cimino, V., Nannini, G., Russo, E., Pallecchi, M., Ramazzotti, M., et al. (2022) · iScience · doi:10.1016/j.isci.2023.106627 · Cited by 18
Sanchez, W. N., Pochapski, J. A., Jessen, L. F., Ellenberger, M., Schwarting, R. K. W., Robinson, D. L., Andreatini, R., & Cunha, C. D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15658 · Cited by 17
Integrative Pharmacology in the Treatment of Substance Use Disorders
Donlon, J., Kumari, P., Varghese, S. P., Bai, M. Y., Florentin, O. D., Frost, E. D., Banks, J., Vadlapatla, N., Kam, O., Shad, M. U., et al. (2023) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2293854 · Cited by 17
Ángeles-Valdéz, D., Rasgado‐Toledo, J., Villicaña, V., Davalos-Guzman, A., Almanza, C., Fajardo-Valdez, A., Alcalá‐Lozano, R., & Garza‐Villarreal, E. A. (2024) · Scientific Data · doi:10.1038/s41597-024-03242-y · Cited by 17
Chéron, J., Beccari, L. L., Hagué, P., Icick, R., Despontin, C., Carusone, T. M., Defrance, M., Bhogaraju, S., Martín‐García, E., Capellán, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-44120-2 · Cited by 16
Shen, Y., & Ward, H. B. (2020) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1841784 · Cited by 17
Predescu, I.-A., Jîjie, A.-R., Pătrașcu, D., Pasc, A.-L.-V., Piroș, E. L., Trandafirescu, C. M., Oancea, C. I., Dehelean, C. A., & Moacă, E.-A. (2025) · Pharmacy · doi:10.3390/pharmacy13010007 · Cited by 15
Guerrin, C. G. J., Tesselaar, D. R. M., Booij, J., Schellekens, A., & Homberg, J. R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106311 · Cited by 16
Alegre-Zurano, L., Berbegal-Sáez, P., Luján, M. Á., Cantacorps, L., Martín‐Sánchez, A., García-Baos, A., & Valverde, O. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112708 · Cited by 15
Blayac, L., Ponté, C., Lavaud, M., Micallef, J., & Lapeyre‐Mestre, M. (2022) · Therapies · doi:10.1016/j.therap.2022.10.003 · Cited by 15
Rahimi, O., Cao, J., Lam, J., Childers, S. R., Rais, R., Porrino, L. J., Newman, A. H., & Nader, M. A. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001363 · Cited by 15
Epistemology, Social Work and Substance Use
McNeil, S. R. (2020) · The British Journal of Social Work · doi:10.1093/bjsw/bcaa128 · Cited by 15
The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review
Ramos, C. S., Thornburg, M., Long, K., Sharma, K., Roth, J., Lacatusu, D., Whitaker, R., Pacciulli, D., Loo, S. M., Manzoor, M., et al. (2022) · Cureus · doi:10.7759/cureus.23647 · Cited by 14
Polysubstance addiction patterns among 7,989 individuals with cocaine use disorder
Stiltner, B., Pietrzak, R. H., Tylee, D. S., Nuñez, Y. Z., Adhikari, K., Kranzler, H. R., Gelernter, J. E., & Polimanti, R. A. (2023) · iScience · doi:10.1016/j.isci.2023.107336 · Cited by 14
Allen, M. I., Johnson, B., Kumar, A., Su, Y., Singh, S., Deep, G., & Nader, M. A. (2024) · Addiction Neuroscience · doi:10.1016/j.addicn.2024.100151 · Cited by 14
Thomsen, M., Crittenden, J. R., Lindsley, C. W., & Graybiel, A. M. (2022) · Addiction Biology · doi:10.1111/adb.13145 · Cited by 14
Zillich, E., Belschner, H., Avetyan, D., Andrade-Brito, D., Martínez‐Magaña, J. J., Frank, J., Mechawar, N., Turecki, G., Cabana‐Domínguez, J., Fernàndez‐Castillo, N., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03139-9 · Cited by 13
Corbett, C. M., Miller, E. N. D., Wannen, E. E., Rood, B. D., Chandler, D. J., & Loweth, J. A. (2023) · Neuroendocrinology · doi:10.1159/000531351 · Cited by 13
Polyphosphazene: A New Adjuvant Platform for Cocaine Vaccine Development
Lin, M., Marin, A., Ellis, B. A., Eubanks, L. M., Andrianov, A. K., & Janda, K. D. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00489 · Cited by 13
Liu, J., Wu, R., Seaman, R. W., Manz, K. M., Johnson, B., Vu, J., Huang, Y., Zhang, Y., Robison, A. J., Neve, R. L., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01448-3 · Cited by 13
Kaushik, S., Ahmad, F., Choudhary, S., Mathkor, D. M., Mishra, B. N., Singh, V., & Haque, S. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105270 · Cited by 12
Blunted Neurobehavioral Loss Anticipation Predicts Relapse to Stimulant Drug Use
Mortazavi, L., MacNiven, K. H., & Knutson, B. D. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.07.020 · Cited by 12
Angoa‐Pérez, M., Zagorac, B., Francescutti, D. M., Shaffer, Z., Theis, K. R., & Kuhn, D. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-40892-1 · Cited by 12
Okorom, A. V., Camacho‐Hernandez, G. A., Salomon, K., Lee, K. H., Ku, T. C., Cao, J., Won, S. J., Friedman, J., Lam, J., Paule, J., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02037 · Cited by 12
The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Life · doi:10.3390/life15060834 · Cited by 12
Forget, B., Icick, R., Robert, J., Correia, C., Prevost, M. S., Gielen, M. C., Corringer, P., Bellivier, F., Vorspan, F., Besson, M., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101898 · Cited by 12
Shearer, R. D., Jones, A. A., Howell, B. A., Segel, J. E., & Winkelman, T. N. A. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108894 · Cited by 12
Wang, C. Q. S., Yang, Y., Wang, K., Sun, L., Liu, S. Q., & Luo, J. (2025) · Addiction Science & Clinical Practice · doi:10.1186/s13722-025-00639-x · Cited by 11
Exercise Modulates Brain Glucose Utilization Response to Acute Cocaine
Hanna, C., Hamilton, J., Blum, K., Badgaiyan, R. D., & Thanos, P. K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12121976 · Cited by 11
Hanna, C., Yao, R., Sajjad, M., Gold, M. S., Blum, K., & Thanos, P. K. (2023) · Brain Sciences · doi:10.3390/brainsci13121705 · Cited by 11
D’Ottavio, G., Pezza, S., Modoni, J., Reverte, I., Marchetti, C., Zenoni, S. F., Termine, A., Fabrizio, C., Maftei, D., Lattanzi, R., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70023 · Cited by 11
Angarita, G. A., Hadizadeh, H., Cerdena, I. L., & Potenza, M. N. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1931684 · Cited by 11
Emerging medications and pharmacological treatment approaches for substance use disorders
Raymond, J. S., Athanasopoulos, A. G., Badolato, C. J., Doolan, T. M., Scicluna, R. L., Everett, N. A., Bowen, M. T., & James, M. H. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173952 · Cited by 10
Cocaine Differentially Affects Mitochondrial Function Depending on Exposure Time
Wattad, S., Bryant, G., Shmuel, M., Smith, H. L., Yaka, R., & Thornton, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052131 · Cited by 10
Cong, Z., Yang, L., Zhao, Z., Zheng, G., Bao, C., Zhang, P., Wang, J., Zheng, W., Yao, Z., & Hu, B. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.012 · Cited by 10
Balakrishnan, A. S., Johansen, L. B. E., Lindsley, C. W., Conn, P. J., & Thomsen, M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111079 · Cited by 10
Wei, J., Liu, H., Li, Y., Zhao, D., Wang, B., Wang, H., Wang, L., Wang, K., Yue, J., Zhang, H., et al. (2024) · Journal of Pineal Research · doi:10.1111/jpi.70002 · Cited by 10
Dave, Y. A., Koperska, M., Lucerne, K. E., Shipman, A. L., Zeldin, S. M., Osman, A., Hofford, R. S., & Kiraly, D. D. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578609 · Cited by 9
Trends in cocaine use among United States females of reproductive age, 2005–2019
Orndorff, M., Shipp, G. M., Kerver, J. M., Ondersma, S. J., & Alshaarawy, O. (2023) · American Journal on Addictions · doi:10.1111/ajad.13502 · Cited by 9
Influence of cocaine use reduction on markers of immune function
Stoops, W. W., Shellenberg, T., Regnier, S. D., Cox, D. H., Adatorwovor, R., Hays, L. R., Anderson, D. M., Lile, J. A., Schmitz, J. M., Havens, J. R., et al. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578470 · Cited by 9
Anti-cocaine Vaccine Development: Where Are We Now and Where Are We Going?
Stephenson, R. J., & Tóth, I. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00366 · Cited by 9
Synthetic Anti-Cocaine Nanoaccine Successfully Prevents Cocaine-Induced Hyperlocomotion
Madge, H. Y. R., Alexander, S., Azuar, A., Zhang, J., Koirala, P., Burne, T. H. J., Tóth, I., & Stephenson, R. J. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00889 · Cited by 9
Akins, N. S., Mohammed, S., Pandey, P., Kim, S. J., Mahdi, F., Khan, M. I. H., Moss, E. M., Worth, C. J., Keane, M. M., Chittiboyina, A. G., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00806 · Cited by 9
Luba, R. R., Carpenter, K. M., Evans, S. M., Slonim, J., & Foltin, R. W. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2201851 · Cited by 8
Rasgado‐Toledo, J., Issa‐Garcia, V., Alcalá‐Lozano, R., Garza‐Villarreal, E. A., & González‐Escamilla, G. (2024) · Addiction Biology · doi:10.1111/adb.13381 · Cited by 9
Schmitz, J. M., Suchting, R., Green, C. E., Webber, H. E., Vincent, J. N., Moeller, F. G., & Lane, S. D. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108800 · Cited by 8
Unuma, K., Kaga, H., Funakoshi, T., Nomura, M., Aki, T., & Uemura, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277032 · Cited by 8
Edvardsson, C. E., Zhang, X., Emous, T. A., Adermark, L., Witley, S., Ericson, M., Schmidt, H. D., & Jerlhag, E. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106219 · Cited by 7
Chmiel, J., Chojdak-Łukasiewicz, J., & Leszek, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206511 · Cited by 7
Association Between Religiosity and Spirituality and Cocaine Use: A Systematic Review
Buja, A., Montecchio, L., & Dossi, F. (2024) · Journal of Religion and Health · doi:10.1007/s10943-024-02069-6 · Cited by 7
Liu, Y., Zhou, Z.-X., Lv, Q., Huang, G., Zhang, H., Wang, Y., Chen, J., & Wang, F. (2024) · National Science Review · doi:10.1093/nsr/nwae467 · Cited by 7
Fugazzotto, F., Occhiuto, F., García-Pardo, M. P., & Aguilar, M. A. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136164 · Cited by 7
Modafinil does not reduce cocaine use in methadone-maintained individuals
DeVito, E. E., Poling, J. C., Babuscio, T. A., Nich, C., Carroll, K. M., & Sofuoglu, M. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100032 · Cited by 7
Mauro, P. M., Gutkind, S., Rivera‐Aguirre, A., Gary, D. S., Cerdá, M., Santos, É. C., Castillo‐Carniglia, Á., & Martins, S. S. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103810 · Cited by 7
Morelos-Santana, E., Islas-Preciado, D., Alcalá‐Lozano, R., Gonzalez-Olvera, J. J., & Estrada-Camarena, E. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-51901-2 · Cited by 7
Decoding cocaine-induced proteomic adaptations in the mouse nucleus accumbens
Mews, P., Sosnick, L., Gurung, A., Sidoli, S., & Nestler, E. J. (2024) · Science Signaling · doi:10.1126/scisignal.adl4738 · Cited by 7
Lu, G., Ma, F., Wei, P., Ma, M., Tran, V. N. H., Baldo, B. A., & Li, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00327 · Cited by 7
Cocaine self-administration attenuates brain glucose metabolism and functional connectivity in rats
Rowan, C., Hanna, C., Sajjad, M., Yao, R., Sharafshah, A., Lewandrowski, K., Blum, K., Pinhasov, A., & Thanos, P. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324522 · Cited by 7
Exercise Influences the Brain’s Metabolic Response to Chronic Cocaine Exposure in Male Rats
Powell, A., Hanna, C., Sajjad, M., Yao, R., Blum, K., Gold, M. S., Quattrin, T., & Thanos, P. K. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050500 · Cited by 6
Atomoxetine Reduces Decisional Impulsivity in Human Cocaine Addiction
Lim, T. V., Cardinal, R. N., Ziauddeen, H., Regenthal, R., Sahakian, B. J., Robbins, T. W., & Ersche, K. D. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.10.018 · Cited by 6
Medigue, I., Catoire, S., Peyron, C., Geoffroy, P. A., Bernabeu, T., Peter‐Derex, L., & Rolland, B. (2025) · European Psychiatry · doi:10.1016/j.neubiorev.2025.106278 · Cited by 6
Barbosa-Méndez, S., López-Morado, C., & Salazar‐Juárez, A. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173237 · Cited by 6
Turpin, M. A. C., Rowland, K. C., Anugwom, C., Arocha, M., Carona, A., Gonzalez, B. I., Iskander, G., Snyder, S., Wilson, K., Kaye, A. D., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98814-8.00027-5 · Cited by 6
Ketamine for Adults With Substance Use Disorders
Tran, K. T., & MacDougall, D. (2024) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2024.845 · Cited by 6
Metadata
- Authors
- Kampman, K. M.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kampman, Kyle M.
- ORCID
- Kampman, Kyle M.
- Venue
- Science Advances
- Published
- 2019-10-11
- Volume
- 5
- Issue
- 10
- Pages
- eaax1532-eaax1532
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6795516
- OpenAlex
- W2981018657
- Cited by
- 250
- References
- 71
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 43 · 2023: 41 · 2022: 47 · 2021: 28 · 2020: 12
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- cocaine dependence, cocaine addiction treatment, psychosocial interventions, contingency management, cognitive behavioral therapy, drug augmentation, dopamine agonists, modafinil, topiramate, glutamatergic agents, GABAergic agents, combination drugs
- MeSH terms
- Animals, Cocaine, Humans, United States, Dopamine Agonists, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.